Biosynex Stock
Stocks
ALBIO
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
19:55:00 03/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.8820 EUR | +0.23% |
|
-4.13% | +47.99% |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact |  |
| 06-11 | Triple update for Biosynex | |
| Market Cap | 16.22M 18.85M 15.22M 13.93M 25.99M 1.78B 26.2M 180M 70.12M 911M 70.79M 69.25M 2.93B | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 69.41M 80.67M 65.14M 59.59M 111M 7.63B 112M 771M 300M 3.9B 303M 296M 12.55B | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALBIO | Real-time | |
Deutsche Boerse AG
| 0DL | Delayed | |
|
Börse Stuttgart
| 0DL | Delayed | |
|
Boerse Muenchen
| 0DL | Real-time | |
|
CBOE
| Real-time | ||
|
CBOE
| Real-time |
| 1 day | +0.23% | ||
| 1 week | -4.13% | ||
| Current month | -1.78% | ||
| 1 month | -4.13% | ||
| 3 months | -4.13% | ||
| 6 months | +3.76% | ||
| Current year | +47.99% |
| 1 week | 0.81 |  | 0.92 |
| 1 month | 0.81 | | 1 |
| Current year | 0.56 | | 1.57 |
| 1 year | 0.46 | | 1.57 |
| 3 years | 0.46 | | 10.9 |
| 5 years | 0.46 | | 28.78 |
| 10 years | 0.46 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 24/06/2015 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/01/2015 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 24/06/2015 |
Thomas Lamy
BRD | Director/Board Member | - | 24/06/2015 |
Larry Abensur
CHM | Chairman | 71 | 24/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/02/23 | Buy | Director | 2,500 | 0.0244% | ||
| 15/02/23 | Buy | Director | 2,500 | 0.0244% | ||
| 28/02/22 | Buy | Chief Executive Officer | 2,000 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -4.13% | -24.62% | -91.83% | 18.8M | |
| -1.85% | -4.87% | +146.41% | +354.02% | 21.88B | |
| +0.46% | +0.60% | -35.58% | -20.60% | 10.31B | |
| +0.05% | -5.16% | +361.03% | +17.19% | 8.03B | |
| -0.91% | -6.67% | -33.10% | - | 7.01B | |
| +0.06% | +0.43% | +82.96% | +52.77% | 6.58B | |
| -0.65% | -2.39% | -19.20% | -20.52% | 5.92B | |
| +0.50% | -0.31% | -9.97% | -20.34% | 4.38B | |
| -0.26% | +1.36% | +73.96% | +83.74% | 4.26B | |
| -0.42% | -1.38% | -19.61% | -27.96% | 2.8B | |
| Average | -0.29% | -2.03% | +52.23% | +36.27% | 7.12B | |
| Weighted average by Cap. | -0.66% | -2.65% | +86.42% | +125.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 101M 118M 94.94M 86.86M 162M 11.12B 163M 1.12B 437M 5.68B 442M 432M 18.29B | 95.19M 111M 89.33M 81.73M 153M 10.46B 154M 1.06B 412M 5.34B 415M 406M 17.21B |
| Net income | -43.33M -50.36M -40.66M -37.2M -69.44M -4.76B -69.99M -481M -187M -2.43B -189M -185M -7.84B | -58.22M -67.67M -54.64M -49.99M -93.3M -6.4B -94.04M -646M -252M -3.27B -254M -249M -10.53B |
| Net Debt | 52.94M 61.52M 49.68M 45.45M 84.83M 5.82B 85.5M 588M 229M 2.97B 231M 226M 9.57B | 53.19M 61.82M 49.91M 45.67M 85.24M 5.84B 85.91M 590M 230M 2.99B 232M 227M 9.62B |
Employees
397
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | €0.8820 | +0.23% | 2,792 |
| 02/09/26 | €0.8800 | -1.57% | 19,500 |
| 01/09/26 | €0.8940 | -0.45% | 6,413 |
| 31/08/26 | €0.8980 | -0.22% | 2,129 |
| 28/08/26 | €0.9000 | -2.17% | 3,237 |
- Stock Market
- Stocks
- ALBIO Stock
Select your edition
All financial news and data tailored to specific country editions
